Letters to Editor endings. Neurotoxic paralysis may begin within the first hour of snake bites and is seen first as ptosis and then as blurred vision and diplopia. This is followed by facial weakness, dysphagia, and dysarthria. The postsynaptic toxicity may be reversed by antivenom that may facilitate the dissociation of toxin from the receptor and accelerate recovery or facilitate a response to anticholinesterase therapy.
Our case is an atypical presentation of acquired strabismus fixus following a neurotoxic snake bite. This occurrence could be as a result of unresolved prolonged oculomotor paresis or due to a prolonged up rolling of eyes due to Bell's phenomenon in an unconscious state during the ICU stay.
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Wolfram (DIDMOAD) syndrome with ventral central pontine hyperintensity without brainstem atrophy Sir, A 27-year-old male, diagnosed to be having a juvenile-onset diabetes mellitus and bilateral sensory neural hearing loss, presented with an 8-year history of gradually progressive visual loss. The history was suggestive of the typical Wolfram (DIDMOAD, Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness) syndrome. He had features of hypogonadism, and no other neurological symptoms or signs were noted. His best corrected visual acuity was 3/60 N36 in the right eye and 6/60 N18 in the left eye. Fundus examination showed temporal disc pallor with moderate non-proliferative diabetic retinopathic changes in both eyes. Visual evoked potential (VEP) was not elicitable in both the eyes. His visual field charting revealed severe visual field defects with macular sparing [ Figure 1 Wolfram syndrome 1 (WFS1) is a rare autosomal recessive genetic disorder, in which optic atrophy, diabetes mellitus, and hearing loss are associated with diabetes insipidus, commonly due to the mutation of the WFS1 gene on chromosome 4p16.1. Wolfram syndrome 2, in which optic atrophy, diabetes mellitus, and hearing loss are seen, but not diabetes insipidus, is caused by CISD2 gene mutation. [1] Juvenile-onset diabetes mellitus and optic atrophy are minimal requirements for the diagnosis of both the varieties of WS, whereas sensorineural hearing loss, ataxia, and urinary tract problems are the other major symptoms, [2] with or without diabetes insipidus. Juvenile diabetes mellitus is probably the first clinical manifestation of the syndrome, whereas visual deterioration and hearing loss present during the second or third decade of life. Ataxia or imbalance is one of the common neurological problems seen in up to 60% of patients; [2] psychiatric symptoms [3, 4] and cognitive impairment are the other less common neurological presentations.
MRI findings previously described in this syndrome are brainstem atrophy, [5] optic tract atrophy, absent posterior pituitary T1 bright spot, cerebellar atrophy, and third ventricular atrophy. [6] Although optic tract atrophy was reported in 100% of cases in larger series, [6] in our case, there was no evidence of optic tract atrophy; however, the visual evoked potential (VEP) was inelicitable. This was attributed to sparing of some proportion of optic tract fibres sufficient enough to preserve his macular vision and give a normal MRI appearance but inadequate to give a positive response on VEP testing. Mild T1 hyperintensities in bilateral globus pallidi were probably suggestive of a more widespread degenerative process even in the absence of gross cerebral parenchymal atrophy. This finding is in accordance with a previous study, in which multimodal imaging demonstrated brain abnormalities even in the early stage of the syndrome. [7] Previously reported cases showed either normal or absent posterior pituitary signal intensity on T1 weighted images; however, in our case, the posterior pituitary T1 bright spot was small but discernable. Due to progressive degeneration of supraoptic and paravertentricular nuclei, posterior pituitary atrophy may occur. This may lead to the absence of the posterior pituitary bright spot in the late stages, as well as its its presence in the early stages of the disease. Probably, our case is representative of an intermediate stage of degeneration in the spectrum. Moderate atrophy of 
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xxxxx the brainstem and cerebellum was described as the first sign even in patients without clinical evidence of neurological problems; [3] however, the first sign in our case was T2/FLAIR hyperintensity in the central and ventral pons without atrophy. The possible etiology of this hyperintensity is the degeneration of the ventral nucleus of trapezoid body, that represents the major decussation of the central auditory pathway. As the patient had residual hearing for low frequencies, he did not have the advanced stage of the disease. Probably, only patients in an advanced stage produce the typical central and bilateral paramedian T2/FLAIR hyperintensities of ventral lower pons with associated atrophy. [8] In conclusion, we report a case of WS with T2/FLAIR hyperintensity in the ventral midline pons in the absence of brain atrophy. The presence of T2/FLAIR hyperintensity in anterior central pons could be one of the initial MRI abnormalities of the brain. In addition, our case describes the additional MRI findings associated with the syndrome, that is, bilateral globus pallidi T1 hyperintensities, and a small posterior pituitary T1 bright spot.
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Commentary: Wolfram (DIDMOAD) syndrome: A progressive disorder with nonsynchronized clinical and imaging features
The authors report the case of a 27-year-old male patient who presented with progressive visual diminution, bilateral sensorineural hearing impairment, and history of juvenile-onset diabetes mellitus; however, cranial magnetic resonance imaging (MRI) revealed paucity of neuroimaging abnormality, which was only limited to the ventral pons and optic radiation showing a hyperintense signal, despite marked endocrinal and neurological deficit. In Wolfram syndrome, the clinical and imaging findings may not always appear in synchrony, with either radiological features preceding the onset of clinical features or vice versa. [1] Wolfram syndrome is a rare, autosomal recessive genetic disease with an estimated prevalence of approximately 1 in 770,000 people. [2] It is characterized by the presence of juvenile-onset insulin-dependent diabetes mellitus, bilateral optic nerve atrophy, diabetes insipidus, along with hearing impairment and symptoms related to the dysfunction of various regions of brain caused by degeneration. [2] Wolfram syndrome is caused by mutation of Wolfram syndrome type 1 (WSF1) gene, which is responsible for coding wolframin and maps to chromosome 4p. [3] The WSF1 gene loss causes chronic endoplasmic reticulum stress-mediated apoptosis of cells
